Literature DB >> 19372177

The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Management of mycoses in neutropenic patients: a brief history, 1960-2008.

John E Bennett1.   

Abstract

The career that this symposium honours, that of Ben E. de Pauw, MD, PhD, could be said to have begun in 1970 upon his graduation from the University of Amsterdam. However, it was his move to Nijmegen in 1975 to finish his PhD studies that really began the career in which he forged expertise in haematology, oncology, immunology and infectious diseases into one spectacular career that resulted in more than 200 publications.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19372177      PMCID： PMC3143421          DOI： 10.1093/jac/dkp079

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


  16 in total

Review 1.  Ocular manifestations of Candida septicemia: review of seventy-six cases of hematogenous Candida endophthalmitis.

Authors:  J E Edwards; R Y Foos; J Z Montgomerie; L B Guze
Journal:  Medicine (Baltimore)       Date:  1974-01       Impact factor: 1.889

Review 2.  Aspergillosis. The spectrum of the disease in 98 patients.

Authors:  R C Young; J E Bennett; C L Vogel; P P Carbone; V T DeVita
Journal:  Medicine (Baltimore)       Date:  1970-03       Impact factor: 1.889

Review 3.  Opportunistic invasive fungal infections in patients with leukaemia lymphoma.

Authors:  J A Krick; J S Remington
Journal:  Clin Haematol       Date:  1976-06

4.  Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia.

Authors:  P A Pizzo; K J Robichaud; F A Gill; F G Witebsky
Journal:  Am J Med       Date:  1982-01       Impact factor: 4.965

5.  Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

Authors:  S Ascioglu; J H Rex; B de Pauw; J E Bennett; J Bille; F Crokaert; D W Denning; J P Donnelly; J E Edwards; Z Erjavec; D Fiere; O Lortholary; J Maertens; J F Meis; T F Patterson; J Ritter; D Selleslag; P M Shah; D A Stevens; T J Walsh
Journal:  Clin Infect Dis       Date:  2001-11-26       Impact factor: 9.079

6.  Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

Authors:  Raoul Herbrecht; David W Denning; Thomas F Patterson; John E Bennett; Reginald E Greene; Jörg-W Oestmann; Winfried V Kern; Kieren A Marr; Patricia Ribaud; Olivier Lortholary; Richard Sylvester; Robert H Rubin; John R Wingard; Paul Stark; Christine Durand; Denis Caillot; Eckhard Thiel; Pranatharthi H Chandrasekar; Michael R Hodges; Haran T Schlamm; Peter F Troke; Ben de Pauw
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

Review 7.  Flucytosine.

Authors:  J E Bennet
Journal:  Ann Intern Med       Date:  1977-03       Impact factor: 25.391

8.  Clotrimazole (Bay b 5097): in vitro and clinical pharmacological studies.

Authors:  M A Burgess; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

Review 9.  The lipid formulations of amphotericin B.

Authors:  Raoul Herbrecht; Shanti Natarajan-Amé; Yasmine Nivoix; Valérie Letscher-Bru
Journal:  Expert Opin Pharmacother       Date:  2003-08       Impact factor: 3.889

10.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.